19 May 2013
Keywords: compugen, abbott, extend, deal, drug, major, laboratories
Article | 23 February 2004
US drug major Abbott Laboratories has extended its agreement with Compugen, under which the former will use the latter's technology ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
23 February 2004
16 February 2004
17 May 2013
© 2013 thepharmaletter.com